D-Mannose for Urinary Tract Infections: What 598 Women in the Largest Study to Date Show
Cranberry, vitamin C, antibiotic alternatives: What the 2023/2024 body of evidence on D-Mannose, cranberry, and vaginal estrogen for recurrent urinary tract infections really shows – beyond the wellness promises.
Briefly explained (TL;DR)
D-Mannose is considered a popular remedy for recurrent bladder infections in Germany. However, the largest and most methodologically rigorous study to date – 598 women, double-blind, JAMA Internal Medicine 2024 – found no statistically significant difference compared to a placebo (51.0% vs. 55.7% recurring infections).
Cranberry, on the other hand, is better supported: The current 2023 Cochrane Review (50 studies, 8,857 participants) concludes that cranberry products likely reduce recurrences in women with laboratory-confirmed, recurrent infections – though not in every target group.
For postmenopausal women, another Cochrane Review shows a clear risk reduction through vaginal (not oral) estrogen. This article soberly assesses the current evidence – without selling a single remedy.
Important medical notice
This article does not replace medical diagnosis or treatment. An acute bladder infection with fever, flank pain, blood in the urine, or symptoms lasting longer than 48 hours requires medical evaluation – if left untreated, an ascending infection can reach the kidneys.
Dietary supplements like D-Mannose are not pharmaceuticals and do not replace antibiotic therapy prescribed by a doctor for an existing infection.
Why D-Mannose is so popular – and why that alone says nothing about its effectiveness
Urinary tract infections (UTIs) are among the most common bacterial infections in women, and some of those affected experience them repeatedly. Those who would rather not take antibiotics over and over again quickly encounter D-Mannose – a simple sugar sold in pharmacies, drugstores, and online shops as powder or capsules.
The popularity of D-Mannose stems from a plausible mechanism: Certain E. coli bacteria attach to sugar structures on the bladder lining via so-called FimH adhesins. D-Mannose is intended to block these docking sites so that the bacteria are flushed out with the urine instead of settling.
However, a plausible mechanism is not proof of efficacy. It was exactly this gap – between laboratory logic and actual clinical effect in real patients – that one of the largest randomized controlled trials on this topic closed in 2024.
What the 2024 JAMA study actually shows
A research team led by Gail Hayward investigated in 99 general practices in the United Kingdom whether daily D-Mannose prevents recurring bladder infections in women with at least two infections in six months (or three in twelve months). 598 women were randomized: 303 received 2 grams of D-Mannose powder daily, 295 an optically identical placebo powder – over six months, double-blind.
The result: 51.0% of women in the D-Mannose group (150 of 294 evaluable participants) contacted the practice again due to a suspected bladder infection – compared to 55.7% in the placebo group (161 of 289). The risk difference was -5 percentage points (95% confidence interval: -13% to +3%; p = 0.26) – not statistically significant. Even with secondary endpoints such as the number of antibiotic prescriptions, no relevant difference was found.
This study is not the first on D-Mannose – earlier, smaller studies (including a widely cited paper from the World Journal of Urology, 2014) showed more optimistic results. The 2024 JAMA study, however, is the largest, most methodologically rigorous, and best-controlled investigation on this topic to date – and its result contradicts the common assumption that D-Mannose is a well-proven alternative to antibiotics.
Cranberry: Who the evidence actually looks better for
Unlike D-Mannose, the body of evidence for cranberry products is currently more favorable – though not across the board for everyone. The current Cochrane Review from 2023 evaluated 50 randomized trials with 8,857 participants.
The authors conclude that cranberry products likely reduce recurrences in women with symptomatic, culture-confirmed (lab-chemical), recurrent infections, as well as in children and people after certain urological procedures. In contrast, no or hardly any benefit was found in older people in nursing homes, pregnant women, and people with neurogenic bladder dysfunction. In the evaluated studies, cranberry showed no superiority over antibiotic prophylaxis.
Important for context: This review also rates the quality of the evidence overall as moderate – not as proven beyond doubt. Furthermore, the effect varied significantly depending on the study design, dosage, and actual active ingredient content (proanthocyanidins) of the tested products.
Methenamine hippurate: The prescription option with mixed data
Methenamine hippurate is a prescription medication in Germany and is prescribed by physicians for recurrent infections. A meta-analysis published in 2025 of five randomized studies (216 participants on methenamine, 205 in control groups, average age 56.9 years) describes methenamine hippurate as "non-inferior" to long-term antibiotic prophylaxis.
However, a closer look at the numbers reveals: For symptomatic infection episodes, there was no statistically significant difference compared to the comparison groups (risk ratio 1.15; p = 0.41), and asymptomatic bacteriuria (bacteria in the urine without symptoms) even occurred more frequently with methenamine (risk ratio 1.91; p < 0.0001). The authors themselves call for further randomized studies before a final assessment is possible. Methenamine hippurate is therefore a medical therapy option with potential – not an over-the-counter "natural remedy" and not a clearly proven improvement over a placebo.
Vaginal estrogen: The most clearly supported option for postmenopausal women
After menopause, estrogen levels drop, which changes the lining of the vagina and urethra and can increase the risk of recurrent infections. A Cochrane Review on estrogens in postmenopausal women with recurrent UTIs makes a clear distinction between the modes of administration.
Oral estrogen showed no effect in this evaluation (risk ratio 1.08; 95% CI 0.88–1.33) – no difference compared to placebo. Vaginal (local) estrogen, however, significantly reduced the number of infections in both evaluated studies (risk ratio 0.25 and 0.64 respectively compared to placebo). The authors note, however, that this conclusion is based on only two relatively small studies – an indication of a likely effective option, not a large-scale confirmation.
For women in or after menopause, this is a relevant difference to the popular misconception that "hormones" are generally helpful or generally risky. Anyone working on topics such as nutritional support, sleep, or bone health during this life stage can find more in the VEYT guide Nutritional Supplements During Menopause. A prescription for vaginal estrogen can only be issued by a gynecological practice. If the issue is not infections, but rather involuntary urine loss, our article Bladder Weakness in Women: What Guidelines and Studies Show assesses the evidence, including the role of local estrogens.
Evidence Overview: Which option is suitable for whom
| Approach | Evidence (2023/2024/2025) | Relevant for | What this does not imply |
|---|---|---|---|
| D-Mannose (2 g/day) | Largest RCT to date (n=598, 2024): no significant difference compared to placebo | Women who want to try it as a low-risk option | Not a substitute for medical evaluation for frequent recurrences |
| Cranberry products | Cochrane 2023 (50 RCTs, n=8,857): likely reduces recurrences with confirmed UTI | Women with recurring, lab-confirmed infections | No proven benefit for nursing home residents, pregnant women, neurogenic bladder |
| Methenamine hippurate (Rx) | Meta-analysis 2025 (5 RCTs, n=421): "non-inferior" vs. antibiotics, no sign. difference vs. placebo for symptoms | Physician-prescribed long-term prophylaxis | Not an OTC preparation, further studies needed |
| Vaginal estrogen | Cochrane Review: significant risk reduction (RR 0.25 / 0.64) in 2 studies; oral estrogen without effect (RR 1.08) | Postmenopausal women with recurring infections | Only 2 small studies; only via physician prescription |
| Probiotics (Lactobacillus) | According to Dr. Jen Gunter (gynecologist): currently "no good data" for UTI prevention | General gut flora support | No substitute for UTI-specific measures |
| Drink enough | Weaker, indirect evidence; unanimously cited in AWMF guidelines and all sources | General prevention, all women | Does not replace targeted treatment for acute infection |
What vitamin C and general nutritional supply can do – and what they can't
Vitamin C also appears in many guidebooks as a tip for bladder infections, based on the idea that it could acidify urine and inhibit bacterial growth. The evidence for this is significantly weaker and older than the data on D-mannose or cranberry; robust, current randomized studies specifically for UTI prevention are lacking. Nevertheless, vitamin C remains a building block for normal immune function and cell protection – just without specific, UTI-related evidence of efficacy. Those who would like to keep an eye on their own intake anyway will find the relevant reference values in the VEYT guide Vitamin C dosage; VEYT's own Immune Power C (buffered vitamin C) is a general immune system supplement in this context and not a formula studied for bladder infections.
Similar things apply to probiotics: General support for the gut flora – as described, for example, by a product like the VEYT Gut Health & Probiotics guide – is a separate topic. The specific Lactobacillus strains tested in individual UTI studies are not listed in most over-the-counter probiotic products; a general probiotic should therefore not be confused with a targeted UTI prophylaxis.
What the German guideline says about prevention
The updated AWMF-S3 guideline "Epidemiology, Diagnostics, Therapy, Prevention and Management of Uncomplicated, Bacterial, Community-Acquired Urinary Tract Infections" (registration number 043/044, status September 2024) forms the current professional framework for diagnosis and prevention in Germany and includes, among other things, studies on D-mannose, cranberry, and vaginal estrogen.
→ Source: AWMF Register No. 043/044: S3-Guideline Urinary Tract Infections in Adult Patients, as of 09/2024.
Guidelines of this type generally pursue two goals for uncomplicated urinary tract infections, which also apply to the current AWMF version: restrained diagnostics tailored to the individual risk of recurrence instead of reflex check-ups, and a deliberate weighing of non-antibiotic measures (e.g., fluid intake, D-mannose, cranberry) against long-term antibiotic prophylaxis – also to avoid unnecessary antibiotic use and the development of resistance. Which measure makes sense in an individual case depends on the frequency of recurrence, life stage, and individual risk factors and should be discussed specifically with the treating practice – for the exact current wording of the recommendations, it is worth looking at the freely accessible guideline itself.
VEYT practice checklist: Addressing recurring bladder infections effectively
- Have acute symptoms checked by a doctor – especially in cases of fever, flank pain, or blood in the urine.
- Document recurrence patterns: How often, when, in connection with what (e.g., sexual intercourse, cycle phase, menopause)?
- Drink enough fluid – the easiest basic measure to implement, mentioned in all sources.
- Treat D-mannose or cranberry only as what the data show: a low-risk attempt with realistic expectations, not an antibiotic substitute with a guarantee of efficacy.
- In case of frequent recurrences (≥2/6 months or ≥3/year): talk to a doctor about methenamine hippurate or – after menopause – vaginal estrogen.
- Do not discontinue or replace antibiotics on your own if they have been prescribed by a doctor.
What is not sufficiently proven
"D-Mannose works just as well as antibiotics"
This is usually based on older, smaller studies. The largest and most strictly controlled study to date (2024) found no significant difference compared to placebo – equating it with antibiotics is untenable based on the current data situation.
"Cranberry helps every woman with a bladder infection"
The benefit was primarily seen in laboratory-confirmed, recurrent infections – not in elderly nursing home residents, pregnant women, or people with a neurogenic bladder.
"A probiotic replaces targeted UTI prophylaxis"
According to current assessment, there is no sufficient data basis for this; a general probiotic is no substitute for the specific measures tested in studies.
Expert Perspectives & Protocol Breakdown
Dr. Eric Berg
What he recommends: In his widely read guide on natural UTI measures, Dr. Eric Berg mentions drinking enough (at least 2.5 liters daily), unsweetened cranberry juice, vitamin C (at least 500 mg daily), probiotics with Lactobacillus strains, D-mannose (around 500 mg twice daily) as well as garlic and herbal teas (e.g., bearberry). At the same time, he emphasizes that persistent or worsening symptoms should be clarified by a doctor.
→ Source: Dr. Eric Berg – Top Natural Remedies for a UTI or Urinary Tract Infection
Dr. Josh Axe
What he recommends: Dr. Josh Axe describes D-mannose as a promising natural alternative to antibiotics and states as a preventative dosage 2 grams of powder in 200 ml of water daily for six months. He relies on older comparative studies in which D-mannose performed similarly to or sometimes better than antibiotic prophylaxis. At the same time, he expressly points out that there is "no uniform standard dosage," that side effects such as bloating or diarrhea are possible, and that the data situation overall requires further research.
→ Source: Dr. Josh Axe – D-Mannose: A Sugar to Prevent Recurrent UTIs?
Dr. Jen Gunter
How she classifies it: Dr. Jen Gunter, a practicing gynecologist and well-known author on evidence-based women's health, takes a more cautious but generally open position on D-mannose in her newsletter "The Vajenda": She describes the evidence as existing but of "lower quality" and recommends that readers who want to try it buy D-mannose individually (instead of in expensive bundle products). She is much more critical of commercial multi-product systems like Uqora: She calls claims about "flushing" the urinary tract medically nonsensical, calls statements about biofilm effects without peer-reviewed evidence misleading – and regarding probiotics for UTI prevention, she notes that there is simply "no good data."
→ Source: Dr. Jen Gunter – The Vajenda: Preventing UTIs, can you tell me about Uqora?
Where They Differ
Dr. Berg and Dr. Axe come from a naturopathic/functional medicine background and tend to present D-mannose more optimistically as an evidence-based antibiotic alternative, supported by older, smaller studies. Dr. Gunter, as a practicing specialist closer to clinical research, formulates her position more cautiously from the outset ("lower quality" of evidence) and directs her criticism primarily against commercial exaggeration, not against the active ingredient itself. None of the three quoted contributions has yet incorporated the large JAMA study from 2024 – their assessments reflect the state of knowledge prior to this study.
What the Evidence Says
The most current and methodologically strongest evidence available (JAMA Intern Med 2024) is more restrained than all three expert assessments quoted here: It finds no significant effect of D-mannose compared to placebo. This does not necessarily mean that D-mannose is ineffective for every individual woman – individual courses can deviate from study averages – but it does mean that the blanket statement "D-mannose is scientifically proven to be effective" is no longer tenable according to the current state of knowledge. Cranberry and, for postmenopausal women, vaginal estrogen are the better-supported non-antibiotic options according to the current data.
Frequently asked questions about D-mannose and bladder infections
Does D-mannose really help against bladder infections?
The largest and most strictly controlled study to date (JAMA Intern Med, 2024, 598 women) found no statistically significant difference compared to placebo. Previous, smaller studies sometimes showed more positive results but are considered methodologically weaker.
How much D-mannose should one take?
In the quoted studies and expert sources, 2 grams daily (sometimes divided into 500 mg twice daily) were mostly used for up to six months. A uniform, officially established dosage does not exist.
Is cranberry better than D-mannose?
According to the current study situation, the evidence for cranberry is slightly more favorable than for D-mannose in women with laboratory-confirmed, recurrent infections, although here too the Cochrane authors speak only of a probable (not securely proven) effect.
Can D-mannose be taken in addition to antibiotics?
This should be discussed with the treating practice. D-mannose does not replace antibiotic therapy prescribed for an acute infection.
Does vitamin C help against bladder infections?
Robust current studies specifically on UTI prevention are lacking. Vitamin C remains a building block of normal immune function, but without specific proof of efficacy for this indication.
What helps women during menopause against recurrent bladder infections?
A Cochrane review shows a significant reduction in risk for postmenopausal women with recurrent infections using vaginal (not oral) estrogen. Prescription is provided by a physician/gynecologist.
When should I go to the doctor with a bladder infection?
Medical clarification is necessary in cases of fever, flank pain, blood in the urine, symptoms during pregnancy, or if symptoms do not improve after 48 hours.
Is D-mannose safe during pregnancy?
According to current knowledge, there is insufficient safety evidence for this; intake during pregnancy should only take place after consultation with the treating practice.
References & Scientific Citations
- Hayward G, Mort S, Hay AD, et al. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. JAMA Intern Med. 2024;184(6):619–628.
- Williams G, et al. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023;CD001321.
- Effectiveness of methenamine hippurate in preventing urinary tract infections: systematic review, meta-analysis and trial sequential analysis. BMC Urol. 2025.
- Perrotta C, et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev.
- AWMF-Register-Nr. 043/044: S3-Leitlinie Harnwegsinfektionen bei erwachsenen Patient:innen, Stand 09/2024.
- Dr. Eric Berg – Top Natural Remedies for a UTI or Urinary Tract Infection
- Dr. Josh Axe – D-Mannose: A Sugar to Prevent Recurrent UTIs?
- Dr. Jen Gunter – The Vajenda: Preventing UTIs, can you tell me about Uqora?
Source transparency: The mentioned physicians are used as perspective sources and stand editorially independent alongside the scientific analysis. Clinical statements on diagnosis and prevention are primarily oriented toward the AWMF guideline, Cochrane reviews, and the cited JAMA study. VEYT does not assume any recommendation of individual experts or their products through this mention.
